|
Post by thinkinkmesa on Jun 6, 2011 17:02:52 GMT -5
Lundbeck finally accepts it must act on execution drugs Maya Foa, of the Legal action charity Reprieve, today met with the Chief Executive of Lundbeck, the pharmaceutical company which has been supplying lethal injection drugs to US death rows. During the meeting, Lundbeck's CEO, Ulf Wiinberg, told Ms Foa that the company has reconsidered its position - which Reprieve has said from the beginning was untenable. Mr Wiinberg now acknowledges that there are steps that the company could take to restrict the distribution of pentobarbital (also known as Nembutal) so that it is not delivered to execution chambers in the US, but still reaches legitimate users. More;www.reprieve.org.uk/2011_06_06_Lundbeck_meeting_Wiinberg
|
|
|
Post by thinkinkmesa on Jun 8, 2011 12:59:57 GMT -5
|
|
|
Post by thinkinkmesa on Jun 30, 2011 22:32:21 GMT -5
Drug Used in Lethal Injections to Stay on U.S. Market The Danish drugmaker H. Lundbeck A/S will continue to supply the U.S. with the barbiturate pentobarbital (Nembutal) despite its recently controversial use in capital punishment. Pulling the drug "would be a tragedy" for patients with severe epilepsy, the company said. "To withdraw the product would have been the easiest and financially best thing to do -- but when we asked the medical community, they said that would compromise treatment options for patients," Lundbeck CEO Ulf Wiinberg told reporters in London. More; www.medpagetoday.com/PublicHealthPolicy/Ethics/27352
|
|
|
Post by thinkinkmesa on Jul 1, 2011 23:43:23 GMT -5
|
|